Amplifon SpA banner

Amplifon SpA
LSE:0N61

Watchlist Manager
Amplifon SpA Logo
Amplifon SpA
LSE:0N61
Watchlist
Price: 9.571 EUR -0.45%
Market Cap: €2.2B

EV/OCF

7.9
Current
52%
Cheaper
vs 3-y average of 16.6

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
7.9
=
Enterprise Value
€3.2B
/
Operating Cash Flow
€414.5m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
7.9
=
Enterprise Value
€3.2B
/
Operating Cash Flow
€414.5m

Valuation Scenarios

Amplifon SpA is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (16.6), the stock would be worth €19.98 (109% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+118%
Average Upside
81%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 7.9 €9.57
0%
3-Year Average 16.6 €19.98
+109%
5-Year Average 17.3 €20.85
+118%
Industry Average 12.6 €15.16
+58%
Country Average 11.1 €13.38
+40%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
IT
Amplifon SpA
LSE:0N61
2.1B EUR 7.9 23
US
Mckesson Corp
NYSE:MCK
101.9B USD 9.9 23.5
US
Cencora Inc
NYSE:COR
59.9B USD 15.4 36.9
US
Amerisourcebergen Corp
LSE:0HF3
59.2B USD 15.1 36.4
US
Cardinal Health Inc
NYSE:CAH
47.2B USD 8.6 28.4
AU
Sigma Healthcare Ltd
ASX:SIG
32.1B AUD 55.8 34.9
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
62.6B CNY 12.1 10.9
CN
Huadong Medicine Co Ltd
SZSE:000963
61.7B CNY -3 036.1 21.8
US
Henry Schein Inc
NASDAQ:HSIC
9B USD 16.7 22.6
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW -316.6 89.6
CN
Sinopharm Group Co Ltd
HKEX:1099
60B HKD 0.4 7.2

Market Distribution

In line with most companies in Italy
Percentile
38th
Based on 752 companies
38th percentile
8.1
Low
0.7 — 7
Typical Range
7 — 14.7
High
14.7 —
Distribution Statistics
Italy
Min 0.7
30th Percentile 7
Median 11.1
70th Percentile 14.7
Max 4 040.2

Amplifon SpA
Glance View

Amplifon SpA, a global leader in hearing solutions, crafts its story around a mission to enhance auditory experiences for individuals worldwide. The company, founded in 1950 by Algernon Charles Holland in Milan, Italy, began as a modest venture but evolved into a dominant force in the audiology market. Amplifon operates through an extensive network of clinics and service centers, boasting a widespread presence across Europe, the Americas, Asia-Pacific, and Africa. Each location serves as a hub where highly trained audiologists and specialists offer personalized hearing assessments and consultations. This localized approach allows the company to cater uniquely to each customer's needs, delivering tailored solutions such as hearing aids, devices, and accessories from leading brands, as well as a suite of supportive services. The company's business model effectively harnesses a comprehensive and vertically integrated structure. Amplifon generates revenue by not just selling hearing devices, but also by providing related services like fittings, aftercare, and support. This approach creates a recurring income stream, as customers often require ongoing maintenance and upgrades to their devices. Additionally, Amplifon invests heavily in research and development, ensuring its offerings incorporate the latest technological advancements. By focusing on innovation and customer satisfaction, Amplifon maintains strong relationships with both its suppliers and clientele, fortifying its position in the competitive landscape of hearing solutions. Through a combination of strategy, service, and an unwavering commitment to quality, the company continues to expand its influence and drive growth in the global market.

0N61 Intrinsic Value
23.969 EUR
Undervaluation 60%
Intrinsic Value
Price €9.571
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett